mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.06 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.07 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.08 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.08 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.08 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.096 |
0.08 |
mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.08 |